Under the agreement, China-based startup METiS will leverage its proprietary, AI-driven ionizable lipid discovery and ...

The Coalition for Epidemic Preparedness Innovations (CEPI) and the World Bank Group (WBG), together with Asian Venture ...

South Korea-based startup NeuroXT Inc., a medical device manufacturer, has announced that NEXT-Cue, its AI-based Software as a Medical Device (SaMD) supporting prognostic assessment in patients with ...

SGH Professor Marcus Ong becomes the first Singapore emergency medicine physician elected to the US National Academy of ...

Under the Agreement, Nxera has granted Synmosa exclusive rights to submit regulatory applications for QUVIVIQ ®, obtain and ...

Merck, known as MSD outside of the United States and Canada, has inaugurated its state-of-the-art ADVANCE research facility ...

HistoIndex partners with A*STAR to advance early-stage development of pipeline therapies for fibrotic diseases in Singapore ...

Seoul National University of Science and Technology researchers show how smartphones can help detect lung problems in ...

S2N.Bio begins technology transfer of its Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility ahead of a ...

Technology can strengthen global clinical development, but it cannot compensate for limitations embedded in trial design. Asia's opportunity extends beyond increasing clinical-trial volume or ...

APACMed CEO Arjun Sarker discusses China and India’s MedTech growth, regulatory convergence and partnerships to expand patient access across Asia Pacific.

Australia-based Telix Pharmaceuticals has announced that the United States (US) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Pixclara® (floretyrosine F 18 or 18 F ...